MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 34 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $757,504 | +7.5% | 244,356 | -1.1% | 0.00% | – |
| Q2 2023 | $704,415 | -52.5% | 247,163 | -34.3% | 0.00% | – |
| Q1 2023 | $1,482,000 | +113376.3% | 376,054 | +14.1% | 0.00% | – |
| Q4 2022 | $1,306 | -99.7% | 329,724 | +514.3% | 0.00% | – |
| Q3 2022 | $493,000 | +2247.6% | 53,675 | +1416.7% | 0.00% | – |
| Q2 2022 | $21,000 | -75.9% | 3,539 | -73.9% | 0.00% | – |
| Q1 2022 | $87,000 | +89.1% | 13,580 | +94.7% | 0.00% | – |
| Q4 2021 | $46,000 | +253.8% | 6,974 | +310.2% | 0.00% | – |
| Q3 2020 | $13,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,750,043 | $11,464,000 | 1.71% |
| Novo Holdings A/S | 2,530,585 | $16,575,000 | 0.78% |
| Boxer Capital, LLC | 2,238,861 | $14,665,000 | 0.57% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,264,000 | 0.41% |
| RA Capital Management | 2,246,503 | $14,715,000 | 0.26% |
| Bleichroeder LP | 250,000 | $1,638,000 | 0.26% |
| PURA VIDA INVESTMENTS, LLC | 931,511 | $6,101,000 | 0.22% |
| Orbimed Advisors | 2,583,821 | $16,924,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,576,000 | 0.11% |
| Eversept Partners, LP | 147,165 | $963,931 | 0.06% |